In This Article:
THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Thursday reported a loss of $33.8 million in its fourth quarter.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 9 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The drugmaker posted revenue of $26.6 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $8.4 million.
For the year, the company reported a loss of $200.4 million, or 63 cents per share. Revenue was reported as $31.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX